Zohar Sachs
@sachszohar
Leukemia Researcher: My lab works on understanding all aspects of TP53 mutant AML and MDS. #AML, #p53, #LeukemiaStemCells, #UniversityofMinnesota
ID: 1161304967254368256
https://med.umn.edu/dom/research/labs/zohar-sachs-lab 13-08-2019 15:54:14
62 Tweet
63 Takipçi
54 Takip Edilen
I am thrilled to share our latest work in Cell Stem Cell which discovers that 5q deletion of lamin B1 in myeloid malignancies drives nuclear anomaly and altered HSC function, led by andreeareilly. Tweetorial and share link below. cell.com/cell-stem-cell…
Amazing great news for GVHD prophy! One of my favorite moments at ASH to see one of smartest and nicest hematologist presenting these exciting results so elegantly!!! Way to go Shernan!!! Shernan Holtan MD Masonic Cancer Center, University of Minnesota #ASH22
Dr. Shernan Holtan (Shernan Holtan MD) discusses her research into a pregnancy hormone that may hold the key to treating life-threatening graft-vs-host diseases and how Teiko helped her overcome the barriers to high-dimensional immune profiling. hubs.ly/Q01xNLW60
Wow! Coverage of the IPSS-M publication during #EHA22 ranked as the top 1 most viewed conference content in 2022 by the #AJMC ajmc.com/view/top-5-mos… Elsa Bernard
Our new manuscript, kudos to Mikkael A. Sekeres MD, MS leading this effort and grateful to the FDA vision to get this panel together. Considerations for Drug Development in Myelodysplastic Syndromes aacrjournals.org/clincancerres/… Amer Zeidan MBBS,MHS عامر زيدان Amy DeZern @KellyNorsworth2 Nina Kim, MD
Outstanding presentation by Monica Guzman. An exciting role for the epichaperone in treating AML. Careful, well designed studies of a single patient can teach us a lot
Stanley Adoro, #aacrAMLMDS cochair Ravi Majeti, Eric R. Lechman, and Monica Guzman discussed Stem Cells in a plenary session at the AACR Special Conference on Acute Myeloid Leukemia and Myelodysplastic Syndrome today in Austin, Texas.
So excited to have NK cell expert and UMN Heme/Onc/Transplant alum, Rizwan Romee back in Minnesota today! Looking forward to a terrific talk and catching up with a dear friend #bmt
Considerations for drug development in #MDS Clinical Cancer Research aacrjournals.org/clincancerres/…
We passed the PRO Act off the Senate floor! After 15 hours of debate, we are tired but jubilant. When Governor Tim Walz signs it, the right to make individual, autonomous decisions about reproductive healthcare, including abortion, will be codified into Minnesota law. #PROAct
Tom on #HealthcareUnfiltered, I host Linda B. Baughn & Yassmine Akkari, PhD two dedicated scientists to tackle & simplify the topic of “Cytogenetics and Cancer.” How did molecular genetics & cancer geneticists change our understanding of cancer? Critical topic; airs in am.
Meanwhile the UMN Medical School M Health Fairview physicians and staff are focused and working very hard. We just quietly became the allogeneic #BMT program with the best survival outcomes in the state despite fewer resources. Why? Our RESEARCH. startribune.com/documents-show…
Beautiful talk using forward genetic screen to identify ERG as a major contributor MDS progression to secondary AML in the mutant p53/(del5q) settings. Zohar Sachs #Ash2023
My #ASH23 highlight: watching my fantastic student, Yoonkyu Lee, present a new scRNA seq analysis method that he developed with terrific collaborator, Chad Myers, (paper 0241).